Jim O'Neill says he spends sleepless nights worrying whether his Review of Antimicrobial Resistance (AMR) will run out of steam once completed in two months' time - but he's encouraged by growing evidence world leaders and the pharma industry are seriously embracing the theme and will soon make lasting commitments to effectively combat antibiotic resistance, including in Asia.
Lord O'Neill of Gatley says the G20 and the United Nations are gradually moving to address the acute need for the dozen or so new antibiotic drugs he believes are needed globally, along with preventative action to curb AMR, importantly including in China.
O'Neill - ex-chair of Goldman Sachs Asset Management and the man appointed by UK Prime Minister David Cameron to launch...